18 results with keyword: 'high diffusion weighted imaging progressive multifocal leukoencephalopathy patients'
However the rim on b3000 diffusion-weighted imaging (DWI) contains a higher proportion of low ADC values (arrows), suggesting that the more stringent delineation of the lesion rim
N/A
However the rim on b3000 diffusion-weighted imaging (DWI) contains a higher proportion of low ADC values ( arrows ), suggesting that the more stringent delineation of the lesion rim
N/A
Keywords: magnetic resonance imaging, natalizumab, multiple sclerosis, progressive multifocal leukoencephalopathy, immune reconstitution inflammatory
N/A
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab. Hall CD, Dafni U, Simpson D,
N/A
For generic custom made stabilizing knee brace for failed total knee replacements, neurological deficits (defined by prescription), quadriceps weakness, knee extension greater than
N/A
Mainstream primary care services, such as private general practices and community health clinics, also have a strong potential to improve the quality of the primary care they
N/A
● When looking at the THEORY, STANDARD INTEGRALS, AN- SWERS or TIPS pages, use the Back button (at the bottom of the page) to return to the exercises.. ● Use the
N/A
• Limited data regarding the risk of drug-induced PML beyond 3 years of MAbs treatment;. • The long-term impact of IRIS therapies is
N/A
ADC/DWI characteristics of PML lesions differ in patients with rapid and slow clinical progression following the initia- tion of HAART therapy, and these findings may aid in
N/A
We describe the characteristics of the 15 patients with fi ngolimod-associated progressive multifocal leukoencephalopathy (PML) identi fi ed from the Novartis data safety base and
N/A
JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased
N/A
: Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy.
N/A
MRI showed an enlargement of the frontal lesion whose posterior border had diffusion restriction on DWI; contrast enhancement appeared at T1-weighted (T1w)
N/A
Natalizumab- associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients: survival and functio- nal outcome when asymptomatic at diagnosis. In AAN
N/A
By applying 454 sequencing on NCCR DNA amplified from body fluid samples (urine, plasma, and cerebrospinal fluid [CSF]) from 19 progressive multifocal leukoencephalopathy
N/A
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.
N/A
Abbreviations used: DTI, diffusion tensor imaging; DWI, diffusion-weighted imaging; DWS, diffusion-weighted spectroscopy; FA, fractional anisotropy; HARDI, high angular
N/A